Under which condition might hypotension occur with dobutamine therapy?

Under which condition might hypotension occur with dobutamine therapy?

• A. If the reduction in SVR is not offset by an increase in CO
• B. If given with diuretics
• C. If the patient has high potassium
• D. If administered intravenously too slowly

Answer: (A)

Dobutamine boosts heart performance by increasing contractility and, to a lesser extent, heart rate, which raises cardiac output. It also causes some vasodilation, lowering systemic vascular resistance. Blood pressure depends on both output and resistance, roughly MAP ≈ CO × SVR. If the vasodilation reduces SVR and the heart does not increase its output enough to compensate, mean arterial pressure falls, leading to hypotension. This is most likely when the heart cannot sufficiently raise CO (for example, with significant LV dysfunction or hypovolemia) so the decrease in SVR is not offset. Other factors like concurrent diuretics can contribute to lower preload and predispose to hypotension, but the fundamental mechanism is the mismatch between decreased vascular resistance and inadequate rise in cardiac output. High potassium levels or slower IV administration aren’t the primary drivers of hypotension in this scenario.

Dobutamine boosts heart performance by increasing contractility and, to a lesser extent, heart rate, which raises cardiac output. It also causes some vasodilation, lowering systemic vascular resistance. Blood pressure depends on both output and resistance, roughly MAP ≈ CO × SVR. If the vasodilation reduces SVR and the heart does not increase its output enough to compensate, mean arterial pressure falls, leading to hypotension. This is most likely when the heart cannot sufficiently raise CO (for example, with significant LV dysfunction or hypovolemia) so the decrease in SVR is not offset.

Other factors like concurrent diuretics can contribute to lower preload and predispose to hypotension, but the fundamental mechanism is the mismatch between decreased vascular resistance and inadequate rise in cardiac output. High potassium levels or slower IV administration aren’t the primary drivers of hypotension in this scenario.